Blocking proteins could pull the plug on power for colon tumors

by Virginia Commonwealth UniversityCredit:Cell Reports(2023). DOI: 10.1016/j.celrep.2023.113081Throughstudy findingspublished inCell Reports, a team of scientists at

Updated on: April 01,2024

Blocking proteins could pull the plug on power for colon tumors

by Virginia Commonwealth UniversityCredit:Cell Reports(2023). DOI: 10.1016/j.celrep.2023.113081Throughstudy findingspublished inCell Reports, a team of scientists at

Updated on:April 01,2024

Cell competition may explain cancer relapses, research suggests

byUT Southwestern Medical CenterCredit:Cancer Discovery(2022). DOI: 10.1158/2159-8290.CD-22-0236A normal process called cell competition, in which healthy tissues eliminate unhealthy

Updated on: January 16,2024

Cell competition may explain cancer relapses, research suggests

byUT Southwestern Medical CenterCredit:Cancer Discovery(2022). DOI: 10.1158/2159-8290.CD-22-0236A normal process called cell competition, in which healthy tissues eliminate unhealthy

Updated on:January 16,2024

Dosing regimen for an old cancer drug shows new promise as an immunotherapy

by Bendta Schroeder,Massachusetts Institute of TechnologyA cancer cell (blue, center) can elude attack by immune cells (such as these T cells shown in green and red) by sequestering the mutated

Updated on: May 20,2024

Dosing regimen for an old cancer drug shows new promise as an immunotherapy

by Bendta Schroeder,Massachusetts Institute of TechnologyA cancer cell (blue, center) can elude attack by immune cells (such as these T cells shown in green and red) by sequestering the mutated

Updated on:May 20,2024

Studies expand and update an encyclopedia of cancer cell lines

by Tom Ulrich,Broad Institute of MIT and HarvardCredit : Susanna M. Hamilton, Broad CommunicationsLarge libraries of cancer cell lines—collections of cells that represent tumor types seen in can

Updated on: June 28,2024

Studies expand and update an encyclopedia of cancer cell lines

by Tom Ulrich,Broad Institute of MIT and HarvardCredit : Susanna M. Hamilton, Broad CommunicationsLarge libraries of cancer cell lines—collections of cells that represent tumor types seen in can

Updated on:June 28,2024

Immune landscape and response to oncolytic virus-based immunotherapy

by Frontiers JournalsCredit:Frontiers of Medicine(2024). DOI: 10.1007/s11684-023-1048-0Oncolytic virus (OV)-based immunotherapy has emerged as a promising strategy for cancer treatment, of

Updated on: August 28,2024

Immune landscape and response to oncolytic virus-based immunotherapy

by Frontiers JournalsCredit:Frontiers of Medicine(2024). DOI: 10.1007/s11684-023-1048-0Oncolytic virus (OV)-based immunotherapy has emerged as a promising strategy for cancer treatment, of

Updated on:August 28,2024

New international exercise guidelines for cancer survivors

by Kerry Blackadar,University of British ColumbiaDr. Kristin Campbell (left), associate professor at UBC's department of physical therapy, with former BC Cancer patient Scenery Slater. Credi

Updated on: April 14,2024

New international exercise guidelines for cancer survivors

by Kerry Blackadar,University of British ColumbiaDr. Kristin Campbell (left), associate professor at UBC's department of physical therapy, with former BC Cancer patient Scenery Slater. Credi

Updated on:April 14,2024

Cherenkov color imaging shows promise in enhancing radiation therapy effectiveness

bySPIEA three-channel camera separates Cherenkov emissions into red, green, and blue channels, allowing the investigation of the impact of variations in melanin and blood levels on the signal. T

Updated on: January 02,2024

Cherenkov color imaging shows promise in enhancing radiation therapy effectiveness

bySPIEA three-channel camera separates Cherenkov emissions into red, green, and blue channels, allowing the investigation of the impact of variations in melanin and blood levels on the signal. T

Updated on:January 02,2024

Analysis calculates $725M in economic potential from expanded cancer treatment access

by Katja Wie, WifORRatio of cost of treatment to GDP per capita. Credit:The Lancet OncologyCommissionA recent analysis,publishedinThe Lancet Oncology, calculates that inc

Updated on: October 24,2024

Analysis calculates $725M in economic potential from expanded cancer treatment access

by Katja Wie, WifORRatio of cost of treatment to GDP per capita. Credit:The Lancet OncologyCommissionA recent analysis,publishedinThe Lancet Oncology, calculates that inc

Updated on:October 24,2024

New delivery strategy may improve chemotherapy for acute myeloid leukemia

byWileyCNL augments the efficacy of cytarabine/venetoclax treatment in in vivo AML models. (A–C) Bioluminescence images (A), their quantification (B) and survival of MOLM-13 Luc-YFP bearing NRG

Updated on: January 11,2024

New delivery strategy may improve chemotherapy for acute myeloid leukemia

byWileyCNL augments the efficacy of cytarabine/venetoclax treatment in in vivo AML models. (A–C) Bioluminescence images (A), their quantification (B) and survival of MOLM-13 Luc-YFP bearing NRG

Updated on:January 11,2024

Researchers discover pathway critical for lymphoma development

by H. Lee Moffitt Cancer Center & Research InstituteActivation of the polyamine-hypusine circuit is a hallmark of human cancer and of MYC-driven lymphoma. A, Copy number alterations (CNA) of

Updated on: February 20,2024

Researchers discover pathway critical for lymphoma development

by H. Lee Moffitt Cancer Center & Research InstituteActivation of the polyamine-hypusine circuit is a hallmark of human cancer and of MYC-driven lymphoma. A, Copy number alterations (CNA) of

Updated on:February 20,2024

Tumor microbiome linked to immunotherapy success in sarcoma patients

by Stephanie Winn,UC DavisSoft tissue sarcomas intratumoral microbiome at diagnosis may link with prognosis. (A) Representative gross examination of extremity synovial sarcoma specimen; asterisk

Updated on: January 22,2024

Tumor microbiome linked to immunotherapy success in sarcoma patients

by Stephanie Winn,UC DavisSoft tissue sarcomas intratumoral microbiome at diagnosis may link with prognosis. (A) Representative gross examination of extremity synovial sarcoma specimen; asterisk

Updated on:January 22,2024

Amivantamab-lazertinib ups survival in EGFR-mutated advanced lung cancer

by Elana GotkineFor patients with EGFR-mutated advanced non-small cell lung cancer (NSCLC), amivantamab-lazertinib yields improved progression-free survival compared with osimertinib as first-line tre

Updated on: July 08,2024

Amivantamab-lazertinib ups survival in EGFR-mutated advanced lung cancer

by Elana GotkineFor patients with EGFR-mutated advanced non-small cell lung cancer (NSCLC), amivantamab-lazertinib yields improved progression-free survival compared with osimertinib as first-line tre

Updated on:July 08,2024